Literature DB >> 24656691

Retinal microvascular abnormalities are associated with early carotid atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes mellitus.

Lian-Xi Li1, Mei-Fang Li1, Jun-Xi Lu1, Li-Li Jia2, Rong Zhang1, Cui-Chun Zhao3, Ying Ren3, Yin-Fang Tu1, Ying Shen1, Fang Liu1, Yu-Qian Bao1, Wei-Ping Jia4.   

Abstract

OBJECTIVE: Controversies concerning the association of retinal microvascular abnormalities (RMAs) with atherosclerosis in patients with diabetes exist. The objective of this study was to investigate the association between RMAs and carotid atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
METHODS: This cross-sectional study involved 2870 type 2 diabetic patients including 1602 men aged 15-90 years and 1268 women aged 17-88 years. Both retinal arteriosclerosis (RA) and diabetic retinopathy (DR) were determined by digital fundus photography using a standardized protocol. RMAs are defined as the presence of either RA or DR. Carotid atherosclerotic lesions including carotid intima-media thickness (CIMT), carotid atherosclerotic plaque and stenosis were assessed and compared between patients with and without RMAs based on Doppler ultrasound. The association of RMAs with carotid atherosclerotic lesions was analyzed by linear and binary logistic regression analyses.
RESULTS: The CIMT values in both male and female diabetics with RMAs were significantly greater than in those without RMAs after controlling for age (0.88±0.21 vs. 0.77±0.20 mm for men, p=0.002; and 0.84±0.19 vs. 0.76±0.21 mm for women, p=0.002). The prevalence of carotid plaque was also markedly higher in patients with RMAs than in those without RMAs after adjusting for age (54.3% vs. 23.9% for men, p<0.001; 48.4% vs. 32.0% for women, p=0.046). However, no significant difference was observed in the prevalence of carotid stenosis in either men or women with or without RMAs. After controlling for multiple confounding factors, RMAs were independently associated with increased CIMT in both men (β: 0.067, 95% CI: 0.026-0.269, p=0.018) and women (β: 0.087, 95% CI: 0.058-0.334, p=0.005) with type 2 diabetes, and they were also closely associated with the presence of carotid plaque (OR: 2.17, 95% CI: 1.54-3.05, p<0.001 for men; OR: 1.38, 95% CI: 0.91-2.08, p=0.129 for women) in men with type 2 diabetes.
CONCLUSIONS: RMAs were closely associated with early carotid atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes. Our results suggested that changes in retinal microvasculature may play a role in the pathogenesis of atherosclerosis and may be used as an indicator of early atherosclerosis in patients with type 2 diabetes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Carotid arteries; Retinal arteriosclerosis; Retinal microvascular abnormalities; Retinopathy; Type 2 diabetes

Mesh:

Year:  2014        PMID: 24656691     DOI: 10.1016/j.jdiacomp.2014.02.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  9 in total

Review 1.  Retinal vascular imaging in early life: insights into processes and risk of cardiovascular disease.

Authors:  Ling-Jun Li; Mohammad Kamran Ikram; Tien Yin Wong
Journal:  J Physiol       Date:  2015-11-23       Impact factor: 5.182

2.  Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes.

Authors:  Lian-Xi Li; Xue-Hong Dong; Mei-Fang Li; Rong Zhang; Ting-Ting Li; Juan Shen; Jing Shen; Yu-Qian Bao; Wei-Ping Jia
Journal:  J Hypertens       Date:  2015-03       Impact factor: 4.844

3.  Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study.

Authors:  Lian-Xi Li; Ai-Ping Wang; Rong Zhang; Ting-Ting Li; Jun-Wei Wang; Yu-Qian Bao; Wei-Ping Jia
Journal:  Cardiovasc Diabetol       Date:  2015-04-15       Impact factor: 9.951

4.  Prevalence and clinical characteristics of lower limb atherosclerotic lesions in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study.

Authors:  Mei-Fang Li; Ying Ren; Cui-Chun Zhao; Rong Zhang; Lian-Xi Li; Fang Liu; Jun-Xi Lu; Yin-Fang Tu; Wei-Jing Zhao; Yu-Qian Bao; Wei-Ping Jia
Journal:  Diabetol Metab Syndr       Date:  2014-06-03       Impact factor: 3.320

5.  Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes.

Authors:  Ming-Yun Chen; Cui-Chun Zhao; Ting-Ting Li; Yue Zhu; Tian-Pei Yu; Yu-Qian Bao; Lian-Xi Li; Wei-Ping Jia
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

6.  The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study.

Authors:  Yimeng Hu; Qinge Li; Rui Min; Yingfeng Deng; Yancheng Xu; Ling Gao
Journal:  PeerJ       Date:  2021-01-13       Impact factor: 2.984

7.  The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes.

Authors:  Mei-Fang Li; Cui-Chun Zhao; Ting-Ting Li; Yin-Fang Tu; Jun-Xi Lu; Rong Zhang; Ming-Yun Chen; Yu-Qian Bao; Lian-Xi Li; Wei-Ping Jia
Journal:  Cardiovasc Diabetol       Date:  2016-03-05       Impact factor: 9.951

8.  The combination of nonthyroidal illness syndrome and renal dysfunction further increases mortality risk in patients with acute myocardial infarction: a prospective cohort study.

Authors:  Jun-Wei Wang; Ying Ren; Zhi-Gang Lu; Jing Gao; Cui-Chun Zhao; Lian-Xi Li; Meng Wei
Journal:  BMC Cardiovasc Disord       Date:  2019-03-04       Impact factor: 2.298

9.  Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review.

Authors:  Ian Pearce; Rafael Simó; Monica Lövestam-Adrian; David T Wong; Marc Evans
Journal:  Diabetes Obes Metab       Date:  2018-10-29       Impact factor: 6.577

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.